Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
532.2 USD | +0.15% | +6.42% | +12.86% |
Apr. 19 | UBS Adjusts Price Target on Elevance Health to $605 From $585, Maintains Buy Rating | MT |
Apr. 19 | Bernstein Adjusts Price Target on Elevance Health to $665 From $629 | MT |
Financials (USD)
Sales 2024 * | 171B | Sales 2025 * | 182B | Capitalization | 124B |
---|---|---|---|---|---|
Net income 2024 * | 8.06B | Net income 2025 * | 9.07B | EV / Sales 2024 * | 0.82 x |
Net Debt 2024 * | 17.19B | Net Debt 2025 * | 12.73B | EV / Sales 2025 * | 0.75 x |
P/E ratio 2024 * |
15.5
x | P/E ratio 2025 * |
13.5
x | Employees | 104,900 |
Yield 2024 * |
1.18% | Yield 2025 * |
1.26% | Free-Float | 99.63% |
Latest transcript on Elevance Health, Inc.
1 day | +0.15% | ||
1 week | +6.42% | ||
Current month | +2.64% | ||
1 month | +3.57% | ||
3 months | +12.80% | ||
6 months | +17.29% | ||
Current year | +12.86% |
Managers | Title | Age | Since |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 23-09-05 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | Feb. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 13-09-30 | |
Director/Board Member | 55 | 22-10-31 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.22% | 18 M€ | +2.56% | - | |
2.36% | 1,026 M€ | +6.11% | - | |
2.07% | 8 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 532.2 | +0.15% | 1,525,124 |
24-04-19 | 531.4 | +1.19% | 1,791,509 |
24-04-18 | 525.2 | +3.19% | 2,595,100 |
24-04-17 | 509 | +0.39% | 1,401,591 |
24-04-16 | 507 | +1.38% | 1,127,280 |
Delayed Quote Nyse, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.86% | 124B | |
-6.69% | 453B | |
+1.85% | 40.43B | |
-28.94% | 39.21B | |
+0.15% | 21.2B | |
-11.08% | 3.18B | |
-41.81% | 947M | |
-34.65% | 308M |
- Stock Market
- Equities
- ELV Stock